Spondyloarthritis & psoriatic arthritis
Report of the International Dermatology Outcome Measures (IDEOM) Meeting Adjacent to the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) 2024 Annual Meeting
Authors' conclusion
IDEOM continues to work to significantly improve patient outcomes and satisfaction in dermatology.
Main finding
As reported in the abstract
- IDEOM HS working group reported on the IDEOM Musculoskeletal Questionnaire (MSK-Q), a PROM for MSK manifestations of psoriatic disease
- Psoriasis Epidemiology Screening Tool (PEST) and Psoriatic Arthritis Impact of Disease (PsAID-12) integrated into the Epic electronic health record system to streamline detection and management of emerging psoriatic arthritis (PsA)
- CTD working group discussed upcoming trials and tools for unmet needs in CLE
- DermSat-7 validated in a multicenter study of patients with psoriasis (PsO); DermSat-11 undergoing validation
Original publication
Report of the IDEOM Meeting Adjacent to the GRAPPA 2024 Annual Meeting. J Rheumatol. Published 5 August 2025. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →